Margaret Mitchell: Unfiltered

A fatal head-on train collision near Machu Picchu leaves one dead and dozens injured, triggering a massive tourist rescue operation by Peruvian authorities.

A new national standard removes the mandatory mechanical steering link, paving the way for radical vehicle designs and cementing China's lead in auto tech.

The investment firm renews its plan to repurchase up to 5% of its units, signaling a strong belief that its market price is below its intrinsic value.

PacBio heads to J.P. Morgan's conference with new tech aimed at making long-read sequencing cheaper. Can it challenge rivals and win over investors?

A 41-year-old mother's massive heart attack on Valentine's Day sparked a miraculous story of survival, advanced medicine, and profound gratitude.

The Danish firm scraps its 2025 revenue forecast, accepting a larger loss in a bold move to secure more lucrative future deals for its key drug candidates.

Vasco Electronics unveils AI that translates presentations in real-time and mimics vocal emotion, pushing the boundaries of multilingual interaction.

Setrusumab, a promising drug for Osteogenesis Imperfecta, failed to reduce fractures in key trials, triggering a market collapse and strategic overhaul.

Ekinops' new high-density module simplifies complex networks, cuts costs, and paves the way for terabit-speed connectivity in the 5G and AI era.

Danish Aerospace Company appoints HC Andersen Capital as its new Certified Advisor, a proactive move prompted by Baker Tilly's exit from the CA market.

As pharma sells GLP-1s directly to patients, doctors are split on the new model. Is it a lifeline for access or a risk to integrated patient care?

A renewed partnership between a top distributor and a leading tech platform signals a major digital evolution for Florida's beverage alcohol industry.

Semrush's new app brings live marketing data directly into ChatGPT, promising a new era of efficiency and reshaping the competitive SaaS battleground.

Leading wellness franchise Prime IV Hydration & Wellness lands major financing to accelerate its rapid expansion in the booming IV therapy market.

The insurance giant launches its first actively managed ETFs, TALV and TABD, leveraging expert sub-advisors to offer established strategies.

A new alliance between EMQ and Volt Active Data promises to deliver a unified device-to-decision platform for mission-critical IoT with unprecedented speed.

A familiar quit-smoking app has been rebuilt into a powerful research tool, powering Australia's largest cessation trial and setting a new standard.

A popular countertop choice is fueling a deadly, incurable lung disease among workers, sparking a public health crisis and a race for safer alternatives.

As AI adoption surges, one firm's rigorous SOC 2 compliance offers a new blueprint for trust in an era of high-stakes data and complex cyber threats.

From biopharma to webcomics, shareholder lawsuits reveal the perils of misleading investors. A look at four companies facing legal and financial fallout.